In this short video, some of the leading figures in the pharma industry talk disruption and transformation-Brexit, US pricing pressures, and the rise of ultra-expensive gene and cell therapies-all subjects to be explored in more depth at this year's FT Pharmaceutical and Biotech Conference on November 11-12 in London. Longer individual interviews can be seen on the FT Live channel's playlist. Further information about the conference, visit live.ft.com/pharmabio
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Real-World Data Demonstrates Efficacy of Apretude and Cabenuva in HIV Prevention, Treatment
March 14th 2025New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and treatment, with Apretude showing zero HIV acquisitions and Cabenuva maintaining high viral suppression rates.